Literature DB >> 26782334

Management of psychiatric and neurological comorbidities in epilepsy.

Andres M Kanner1.   

Abstract

The treatment of epileptic seizure disorders is not restricted to the achievement of seizure-freedom, but must also include the management of comorbid medical, neurological, psychiatric and cognitive comorbidities. Psychiatric and neurological comorbidities are relatively common and often co-exist in people with epilepsy (PWE). For example, depression and anxiety disorders are the most common psychiatric comorbidities in PWE, and they are particularly common in PWE who also have a neurological comorbidity, such as migraine, stroke, traumatic brain injury or dementia. Moreover, psychiatric and neurological comorbodities often have a more severe impact on the quality of life in patients with treatment-resistant focal epilepsy than do the actual seizures. Epilepsy and psychiatric and neurological comorbidities have a complex relationship, which has a direct bearing on the management of both seizures and the comorbidities: the comorbidities have to be factored into the selection of antiepileptic drugs, and the susceptibility to seizures has to be considered when choosing the drugs to treat comorbidities. The aim of this Review is to highlight the complex relationship between epilepsy and common psychiatric and neurological comorbidities, and provide an overview of how treatment strategies for epilepsy can positively and negatively affect these comorbidities and vice versa.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26782334     DOI: 10.1038/nrneurol.2015.243

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  76 in total

1.  International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy.

Authors:  Mike P Kerr; Seth Mensah; Frank Besag; Bertrand de Toffol; Alan Ettinger; Kousuke Kanemoto; Andres Kanner; Steven Kemp; Ennapadum Krishnamoorthy; W Curt LaFrance; Marco Mula; Bettina Schmitz; Ludgers Tebartz van Elst; Julian Trollor; Sarah J Wilson
Journal:  Epilepsia       Date:  2011-09-28       Impact factor: 5.864

2.  Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy?

Authors:  Andres M Kanner; John J Barry; Frank Gilliam; Bruce Hermann; Kimford J Meador
Journal:  Epilepsia       Date:  2010-04-30       Impact factor: 5.864

3.  Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death.

Authors:  Elisabetta Patorno; Rhonda L Bohn; Peter M Wahl; Jerry Avorn; Amanda R Patrick; Jun Liu; Sebastian Schneeweiss
Journal:  JAMA       Date:  2010-04-14       Impact factor: 56.272

4.  An update on antiepileptic drugs and suicide: are there definitive answers yet?

Authors:  Dale C Hesdorffer; Anne T Berg; Andres M Kanner
Journal:  Epilepsy Curr       Date:  2010-11       Impact factor: 7.500

5.  Topiramate dose effects on cognition: a randomized double-blind study.

Authors:  D W Loring; D J Williamson; K J Meador; F Wiegand; J Hulihan
Journal:  Neurology       Date:  2010-12-09       Impact factor: 9.910

Review 6.  Psychotropic effects of antiepileptic drugs.

Authors:  Alan B Ettinger
Journal:  Neurology       Date:  2006-12-12       Impact factor: 9.910

Review 7.  Attention-deficit hyperactivity disorder.

Authors:  Joseph Biederman; Stephen V Faraone
Journal:  Lancet       Date:  2005 Jul 16-22       Impact factor: 79.321

8.  Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein.

Authors:  Scott Mintzer; Christopher T Skidmore; Caitlin J Abidin; Megan C Morales; Inna Chervoneva; David M Capuzzi; Michael R Sperling
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

Review 9.  Preventive migraine treatment.

Authors:  Stephen D Silberstein
Journal:  Neurol Clin       Date:  2009-05       Impact factor: 3.806

10.  Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system.

Authors:  Anne C VanCott; Joyce A Cramer; Laurel A Copeland; John E Zeber; Michael A Steinman; Jeffrey J Dersh; Mark E Glickman; Eric M Mortensen; Megan E Amuan; Mary Jo Pugh
Journal:  BMC Med       Date:  2010-01-11       Impact factor: 8.775

View more
  75 in total

1.  Anandamide Signaling Augmentation Rescues Amygdala Synaptic Function and Comorbid Emotional Alterations in a Model of Epilepsy.

Authors:  Roberto Colangeli; Maria Morena; Quentin J Pittman; Matthew N Hill; G Campbell Teskey
Journal:  J Neurosci       Date:  2020-06-29       Impact factor: 6.167

Review 2.  Resolving the Micro-Macro Disconnect to Address Core Features of Seizure Networks.

Authors:  Jordan S Farrell; Quynh-Anh Nguyen; Ivan Soltesz
Journal:  Neuron       Date:  2019-03-20       Impact factor: 17.173

3.  2014 Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across The Lifespan.

Authors:  Alica M Goldman; W Curt LaFrance; Tim Benke; Miya Asato; Dan Drane; Alison Pack; Tanvir Syed; Robert Doss; Samden Lhatoo; Brandy Fureman; Ray Dingledine
Journal:  Epilepsy Curr       Date:  2016 May-Jun       Impact factor: 7.500

4.  A Nose for Seizures: A Potential Role for Olfaction in the Co-Morbidity of Depression and Epilepsy?

Authors:  Catherine A Christian
Journal:  Epilepsy Curr       Date:  2016 Jul-Aug       Impact factor: 7.500

Review 5.  Dendritic structural plasticity and neuropsychiatric disease.

Authors:  Marc P Forrest; Euan Parnell; Peter Penzes
Journal:  Nat Rev Neurosci       Date:  2018-03-16       Impact factor: 34.870

6.  A Metabolic Paradigm for Epilepsy.

Authors:  Manisha Patel
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

7.  Galanin contributes to monoaminergic dysfunction and to dependent neurobehavioral comorbidities of epilepsy.

Authors:  Jesus-Servando Medel-Matus; Don Shin; Raman Sankar; Andrey Mazarati
Journal:  Exp Neurol       Date:  2016-12-22       Impact factor: 5.330

Review 8.  Should adult neurologists play a role in the management of the most common psychiatric comorbidities? Practical considerations.

Authors:  Heidi M Munger Clary; Jay A Salpekar
Journal:  Epilepsy Behav       Date:  2018-11-22       Impact factor: 2.937

Review 9.  Epilepsy as a Network Disorder (2): What can we learn from other network disorders such as dementia and schizophrenia, and what are the implications for translational research?

Authors:  Helen E Scharfman; Andres M Kanner; Alon Friedman; Ingmar Blümcke; Candice E Crocker; Fernando Cendes; Ramon Diaz-Arrastia; Hans Förstl; André A Fenton; Anthony A Grace; Jorge Palop; Jason Morrison; Astrid Nehlig; Asuri Prasad; Karen S Wilcox; Nathalie Jette; Bernd Pohlmann-Eden
Journal:  Epilepsy Behav       Date:  2017-10-31       Impact factor: 2.937

10.  Objective score from initial interview identifies patients with probable dissociative seizures.

Authors:  Wesley T Kerr; Emily A Janio; Andrea M Chau; Chelsea T Braesch; Justine M Le; Jessica M Hori; Akash B Patel; Norma L Gallardo; Corinne H Allas; Amir H Karimi; Ishita Dubey; Siddhika S Sreenivasan; Janar Bauirjan; Eric S Hwang; Emily C Davis; Shannon R D'Ambrosio; Mona Al Banna; Rajarshi Mazumder; Ting Wu; Zachary A DeCant; Michael G Gibbs; Edward Chang; Xingruo Zhang; Andrew Y Cho; Nicholas J Beimer; Jerome Engel; Mark S Cohen; John M Stern
Journal:  Epilepsy Behav       Date:  2020-11-13       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.